Green Bioactives was a biotechnology firm that developed a platform for the sustainable, plant cell-based production of natural biomolecules for the wellness and personal care industries before entering liquidation in 2025.
Green Bioactives was a Scottish biotechnology company that developed a sustainable plant cell-based biomanufacturing platform. The company's technology involved collecting plant samples, isolating and cultivating stem cells, and scaling production in bioreactors to extract high-value natural plant biomolecules. By growing cells in controlled conditions, the platform sought to provide a reliable and consistent supply of botanicals, addressing issues like supply chain instability, weather-related risks, and contamination, while avoiding traditional large-scale agricultural methods.
This technology aimed to serve industries such as health, wellness, cosmetics, and personal care by providing access to natural compounds in a more sustainable and efficient manner. The company also developed a cognitive-support supplement ingredient, GBL-Memory1, which combined prebiotic fructooligosaccharides and L-theanine. Despite securing grants and demonstrating progress with its technology, Green Bioactives entered liquidation in 2025 following a funding shortfall and a difficult investment environment, leading to the acquisition of its memory-complex ingredient by Harke Pharma GmbH.